As we highlighted the role of each homologous recombination factors (RAD21, RAD50 or BARD1) to patients’ survival and cancer aggressiveness in bladder cancer, other groups studied these factors in different cancer types22,24,28,43,65,66. The gene discussed is RAD21; the disease is urinary bladder carcinoma.